Harvey M. Golomb to Drug Therapy, Combination
This is a "connection" page, showing publications Harvey M. Golomb has written about Drug Therapy, Combination.
Connection Strength
0.149
-
Design of combination biotherapy studies: future goals and challenges. Semin Oncol. 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41.
Score: 0.019
-
Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
Score: 0.015
-
Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1983 Sep; 67(9):831-2.
Score: 0.012
-
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
Score: 0.012
-
Treatment of stage IIIA Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):827-34.
Score: 0.011
-
The non-Hodgkin lymphomas. Curr Probl Cancer. 1980 Jan; 4(7):1-35.
Score: 0.009
-
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
Score: 0.009
-
Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer. 1978 Aug; 42(2 Suppl):946-56.
Score: 0.009
-
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1978 Mar; 62(3):327-32.
Score: 0.008
-
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1976 Sep; 60(9):1225-30.
Score: 0.008
-
Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
Score: 0.003
-
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
Score: 0.003
-
Histiocytic lymphoma: response to chemotherapy. Ann Intern Med. 1982 Oct; 97(4):617-8.
Score: 0.003
-
VP16-213 in combined modality treatment of small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1982 Apr; 18(4):343-6.
Score: 0.003
-
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
Score: 0.003
-
Lymphoblastic lymphoma in adults. Cancer. 1981 May 15; 47(10):2510-6.
Score: 0.003
-
Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
Score: 0.003
-
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med. 1980 Jun; 92(6):785-90.
Score: 0.002
-
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
Score: 0.002
-
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
Score: 0.002
-
Sepsis in treated Hodgkin's disease. Am J Med. 1978 May; 64(5):914-5.
Score: 0.002
-
Central nervous system involvement in patients with histiocytic lymphoma, diffuse type. Blood. 1978 Jan; 51(1):177-9.
Score: 0.002
-
Disseminated malignant lymphoma, histiocytic type: the changing picture. Ann Intern Med. 1976 Oct; 85(4):521-3.
Score: 0.002
-
Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040). Cancer Treat Rep. 1976 Mar; 60(3):221-3.
Score: 0.002
-
Letter: Chemotherapy of advanced histocytic lymphomas. Lancet. 1975 May 17; 1(7916):1136.
Score: 0.002
-
Combination chemotherapy of lymphomas other than Hodgkin's disease. Ann Intern Med. 1974 Nov; 81(5):601-8.
Score: 0.002